NEW Video Breakdown of the Health Tech Investment Act

What is the Health Tech Investment Act, and why does it matter to patients across the country? This bipartisan legislation aims to modernize how Medicare covers breakthrough AI-enabled medical technologies, so patients can access the tools they need when they need them.

Artificial intelligence (AI) and machine learning (ML) integrated in medical devices has the potential to help improve early detection or support more effective treatment for patients. Unfortunately, how these technologies are paid for is often unclear, leading to delays or limiting overall access.

The Health Tech Investment Act, introduced in the U.S. House of Representatives and the Senate, would address this by creating a clear pathway for AI-enabled medical technologies to receive Medicare coverage, significantly expanding access for patients and providers. A new video from AdvaMed and Patients Rising explains exactly how this legislation works.

Health Tech Investment Act Video

By reducing uncertainty and expanding access to medical technologies, the Health Tech Investment Act would ensure patients can benefit from innovations that improve their care.

You can help us advocate for this important legislation by sending a letter to your members of Congress here.

More Articles

Take Action to Protect Patient Safety!

April 11, 2022

Medical imaging devices can catch disease early and save lives, but they’re also complex machines that require extensive…

Device Remanufacturing and Why It Matters to You

March 30, 2022

Medical imaging has revolutionized healthcare, especially over the past 30 years, offering doctors the opportunity to find diseases…

Recognizing Colorectal Cancer Awareness Month

March 9, 2022

Every March, we recognize National Colorectal Cancer Awareness Month as an opportunity to raise awareness about this all-too-common disease…

WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics

January 27, 2022

Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to…